Sort
23,748 grants matching “melanoma”
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma
$151,970Adrienne D Cox · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA
Multidisciplinary Approaches to Tumor Immunology
$151,963Kelvin P Lee · Roswell Park Cancer Institute Corp · T32 · FY2013 · CA
ECOG INSTITUTION GRANT
$151,823University Of South Florida · U10 · FY2002 · CA
Genetic Mechanisms of Immunity and Inflammation in Melonoma Progression
$151,766Jeffrey E Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
RNA Interference Tools Core
$151,616Pedro Aza-Blanc · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA
In-situ activation of antitumor effectors
$151,545Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · CA
Core--Cell
$151,395Anna Karolina Palucka · Baylor Research Institute · P01 · FY2006 · CA
Targeting RAS in Pediatric Cancer
$151,215Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2019 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2020 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2016 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2018 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2017 · CA
Project 1: How tumor ensemble models with two experimental models predict tumor dormancy & reactivation in cancers with gender and/or ethnic disparities
$151,148Richard Mark White · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA
Application protocols for a cancer DNA vaccine
$151,095Ichor Medical Systems, Inc. · R43 · FY2004 · CA
SOCS proteins as inhibitors of immune surveillance in the melanoma microenvironme
$151,014Gregory B. Lesinski · Ohio State University · K22 · FY2009 · CA
Identification of essential biomarkers in the polyploid cancer cell lifecycle
$151,000Christina Voelkel-Johnson · Medical University Of South Carolina · R03 · FY2024 · CA
ECOG INSTITUTION GRANT
$150,955University Of South Florida · U10 · FY2001 · CA
Pathology Core
$150,946Xiaowei Xu · Wistar Institute · P01 · FY2020 · CA
Administration and Coordination Core
$150,834Gaudenz Danuser · Ut Southwestern Medical Center · U54 · FY2023 · CA
Repurposing drugs and finding new therapeutic targets for cutaneous malignancies
$150,823Natasha Hill · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
$150,798Jessie Villanueva · Wistar Institute · K01 · FY2013 · CA
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
$150,798Jessie Villanueva · Wistar Institute · K01 · FY2014 · CA
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
$150,798Jessie Villanueva · Wistar Institute · K01 · FY2017 · CA
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
$150,798Jessie Villanueva · Wistar Institute · K01 · FY2016 · CA